This Solicitation opportunity from Department Of Defense was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MOXIFLOXACIN HYDROC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract calls for the procurement of MOXIFLOXACIN HYDROCHLORIDE tablets in bottles containing 30 tablets each with a dosage of 400 mg. A total of 5 bottles are to be delivered within 20 days to the specified destination. The packaging must comply with the Defense Logistics Agency (DLA) packaging requirements, ensuring the tablets are stored at controlled room temperature with avoidance of high humidity. Packaging and marking must adhere strictly to Medical Marking Standard No. 1, superseding previous military standards, and the materials need to be packaged in sealed containers to prevent damage during shipment. The product carries a shelf life of 36 months, non-extendable, and any hazardous material handling requirements must follow applicable federal standards. The contract is managed under the Department of Defense's Medical Supply Chain, specifically through the Federal Supply Support Activity, with an inspection and acceptance point at the destination. The product is regulated by the FDA, and buyers must coordinate with a product specialist for confirmation, providing complete supplier and manufacturer information. Delivery is FOB destination with no quantity variance allowed. Shipment instructions emphasize the use of the fastest traceable means with restrictions against parcel post, and palletization must conform to DLA packaging requirements. Communication and specific contract details are facilitated through designated contacts associated with the solicitation number SPE2DP-26-T-3478.
General Info
Agency
NAICS
Place of Performance
UNIT 100472 BOX 1, FPO, AP, 96694, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
MOXIFLOXACIN HYDROCHLORIDE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
400 MG 30'S TABLETS PER BOTTLE. UNIT OF ISSUE "BOTTLE". STORE AT
CONTROLLED ROOM TEMPERATURE; AVOID HIGH HUMIDITY .. LABELING AND MARKING
MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY
2013.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 30 EA RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-3478
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RISING PHARMA HOLDINGS, INC. 8FG82 P/N NDC57237-0156-30 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-7387-56
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016833667 0001 BT 5.000
NSN/MATERIAL:6505015034772
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R20170
USS MOBILE (LCS 26) BLUE
AIR DEPARTMENT (HSM49 DET 2)
UNIT 100472 BOX 1
FPO AP 96694
US
SPE2DP-26-T-3478
SECTION B
PR: 7016833667 PRLI: 0001 CONT’D
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R20170
USS MOBILE (LCS-26)
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R201706135M194
RDD: 777
PROJ: ZJ7 TP 2
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:05/21/2026
SPE2DP-26-T-3478 NSN/Part Number: 6505-01-503-4772 Quantity: 5 BT Purchase Request: 7016833667QTY: 5 Delivery: 20 days ADO